López-Pérez, Ó.; Bernal-Martín, M.; Hernaiz, A.; Llorens, F.; Betancor, M.; Otero, A.; Toivonen, J.M.; Zaragoza, P.; Zerr, I.; Badiola, J.J.;
et al. BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers. Biomolecules 2020, 10, 706.
https://doi.org/10.3390/biom10050706
AMA Style
López-Pérez Ó, Bernal-Martín M, Hernaiz A, Llorens F, Betancor M, Otero A, Toivonen JM, Zaragoza P, Zerr I, Badiola JJ,
et al. BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers. Biomolecules. 2020; 10(5):706.
https://doi.org/10.3390/biom10050706
Chicago/Turabian Style
López-Pérez, Óscar, Marcos Bernal-Martín, Adelaida Hernaiz, Franc Llorens, Marina Betancor, Alicia Otero, Janne Markus Toivonen, Pilar Zaragoza, Inga Zerr, Juan José Badiola,
and et al. 2020. "BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers" Biomolecules 10, no. 5: 706.
https://doi.org/10.3390/biom10050706
APA Style
López-Pérez, Ó., Bernal-Martín, M., Hernaiz, A., Llorens, F., Betancor, M., Otero, A., Toivonen, J. M., Zaragoza, P., Zerr, I., Badiola, J. J., Bolea, R., & Martín-Burriel, I.
(2020). BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers. Biomolecules, 10(5), 706.
https://doi.org/10.3390/biom10050706